  Angiotensin II (AngII) type 1 receptor (AT1R) is a G protein-coupled receptor
known for its role in numerous physiological processes and its implication in
many vascular diseases. Its functions are mediated through G protein dependent
and independent signaling pathways. AT1R has several endogenous peptidic
agonists, all derived from angiotensinogen, as well as several synthetic
ligands known to elicit biased signaling responses. Here, surface plasmon
resonance (SPR) was used as a cell- based and label-free technique to quantify,
in real time, the response of HEK293 cells stably expressing the human AT1R.
The goal was to take advantage of the integrative nature of this assay to
identify specific signaling pathways in the features of the response profiles
generated by numerous endogenous and synthetic ligands of AT1R. First, we
assessed the contributions of Gq, G12/13, Gi, Gbg, ERK1/2 and \b{eta}-
arrestins pathways in the cellular responses measured by SPR where Gq,
G12/Rho/ROCK together with \b{eta}-arrestins and ERK1/2 were found to play
significant roles. More specifically, we established a major role for G12 in
the early events of the AT1R-dependent response, which was followed by a robust
ERK1/2 component associated to the later phase of the signal. Interestingly,
endogenous AT1R ligands (AngII, AngIII and AngIV) exhibited distinct responses
signatures with a significant increase of the ERK1/2-like components for both
AngIII and AngIV, which points toward possibly distinct physiological roles for
the later. We also tested AT1R biased ligands, all of which affected both the
early and later events. Our results support SPR-based integrative cellular
assays as a powerful approach to delineate the contribution of specific
signaling pathways for a given cell response and reveal response differences
associated with ligands with distinct pharmacological properties.
